Angle Share Discussion Threads

[ic0gcds00] 15/1/2024 15:18

Wow poor dumpers!!!

[atmysignal] 15/1/2024 14:58

30p? Highly likely

[kilijarslan] 15/1/2024 14:53

Apologies autocorrect. BookbuildingLook at the 25k and 50k blocks that seem to quietly accumulate in the background.

[hsdeo1] 15/1/2024 14:18

I think there is deffo something afoot and not just shorts closing. Against my better judgement I have taken a punt on 25k shares. Upside is 100% and down side 50%. Not too bad I guess.

[waterloo01] 15/1/2024 14:14

Hope the op went OK Mr K.

[bones699] 15/1/2024 13:05

I see fake Bones698 has finally crawled his way out of the cesspit...won't be here for long when this pile of junk hits the floor again later today lol!

[bones699] 15/1/2024 13:02

Yeh Mr K

If all else fails just copy and paste the same stuff over and over again lol!

[mrkeysersoze] 15/1/2024 12:48

I don't think this has been posted before, but an excellent overview of Angle's latest news....

ANGLE’s Parsortix System Unveils Hidden Cancer Mutations

Published: January 4, 2024



ANGLE plc, an industry-leading liquid biopsy company, has revealed its groundbreaking clinical findings using the Parsortix system to analyze blood samples from cancer patients. The system’s unique approach combines the analysis of circulating tumor cell (CTC) DNA and circulating tumor DNA (ctDNA), presenting a more comprehensive understanding of individual cancer progression. Notably, the dual analysis identified cancer mutations in 70% of breast, 70% of lung, and 60% of ovarian cancer patient samples that went undetected in ctDNA analysis alone.
Pioneering a New Era of Cancer Treatment

The mutations identified include those targeted by FDA-approved cancer treatments, indicating the potential of the Parsortix system to guide more effective treatment decisions. This novel insight into both living and dead cancer cells could potentially revolutionize cancer treatment, improving patient outcomes and maximizing the likelihood of treatment success.
Unleashing the Power of Microfluidic Cell Sorting Techniques

The technique leverages recent advances in microfluidic cell sorting, encompassing physical and biological aspects that hold potential benefits for cancer detection and therapy. Circulating tumor cells (CTCs) serve as valuable biomarkers for cancer detection, prognosis, and therapy, but isolating and analyzing them due to their low abundance and diverse properties can be challenging. Microfluidic technology offers a solution for the isolation and characterization of CTCs, as well as the detection and analysis of cancer biomarkers.
Driving Sales with Next Generation Sequencing

ANGLE’s advancement in DNA molecular analysis using Next Generation Sequencing (NGS) systems is anticipated to stimulate sales in both their product and pharma service segments. Its development assists oncologists in tracking cancer evolution, monitoring treatment response, and detecting drug resistance. As a result, ANGLE is now set to offer sample-to-answer DNA molecular solutions to its pharma services customers and is engaging with industry experts to facilitate the clinical adoption of this molecular profiling approach.



Mr K.

[gspanner] 15/1/2024 12:46

Bookbinding? That sounds fun 😂. Predictive text error?

[kilijarslan] 15/1/2024 12:44

Bookbinding going on. Possible teo ii's have been adding for further TR1's

[havinthelasttoast] 15/1/2024 12:33

Here comes the rampers.

[gspanner] 15/1/2024 11:44

Someone tell Astra! 😂

[hsdeo1] 15/1/2024 11:38

There are some hefty buys, maybe the friday seller has reversed his strategy!

[stevehuges] 15/1/2024 11:11

Some big buys incoming , looking to go further north today !

[lawson27] 15/1/2024 10:56

Joined you for a few @18s after the excitement, gap filled, should see the next leg up, GLA

[astra1vision] 15/1/2024 10:23

Paid rampers and employees on here were pumping this hard last week stating this would fly short term. Wonder how many mugs got lured in by these criminals.

[hsdeo1] 15/1/2024 10:00

Not sure this someone accumulating!

[purchaseatthetop] 15/1/2024 10:00

Yes. Seems so. This share needs some revenue and then it will soar. The only problem is the lack of revenue so far.

[barrywhit] 15/1/2024 09:58

Looks to me like just traders...rinse and repeat...

[purchaseatthetop] 15/1/2024 09:54

Will be interesting to see if this is a MM created spike to clear shares or a real recovery!

[kirk 6] 15/1/2024 09:46

Can't buy any now 20p about to be smashed

[boris cobaka] 15/1/2024 09:40

Morning.
The lack of further TR1's is surprising considering the huge volume after the last announcement. Perhaps it means they haven't finished accumulating.....